Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R Pelkey
Patient Benefits and Cost Savings Predicted for Mineralocorticoid-Receptor Antagonist Treatment of Early and Advanced Diabetic Kidney Disease
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Monitoring Renal Safety in Mineralocorticoid Receptor Antagonist Trials
European Journal of Heart Failure
Cardiovascular Medicine
Cardiology
Erratum. Comparison of Kidney Transcriptomic Profiles of Early and Advanced Diabetic Nephropathy Reveals Potential New Mechanisms for Disease Progression. Diabetes 2019;68:2301–2314
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Diabetic Kidney Disease
Nature Reviews Disease Primers
Medicine
Aldosterone and the Mineralocorticoid Receptor in Renal Injury: A Potential Therapeutic Target in Feline Chronic Kidney Disease
Journal of Veterinary Pharmacology and Therapeutics
Veterinary
Pharmacology
Successful Pregnancy and Childbirth in a Patient With Diabetic Kidney Disease Receiving Hemodialysis
Soonchunhyang Medical Science
Current and Emerging Treatment Options for the Elderly Patient With Chronic Kidney Disease
Clinical Interventions in Aging
Medicine
Gerontology
Geriatrics
Significance of AT1 Receptor Independent Activation of Mineralocorticoid Receptor in Murine Diabetic Cardiomyopathy
PLoS ONE
Multidisciplinary
Managing the Diabetic Kidney Patient
Journal for Nurse Practitioners
LPN
Fundamentals
Skills
Advanced
LVN
Specialized Nursing
Differential Impacts of Mineralocorticoid Receptor Antagonist Potassium Canrenoate on Liver and Renal Changes in High Fat Diet-Mediated Early Hepatocarcinogenesis Model Rats
Journal of Toxicological Sciences
Medicine
Toxicology